May 1, 2018 / 8:51 PM / 5 months ago

BRIEF-Rigel Pharmaceuticals Q1 Loss Per Share $0.17

Rigel Pharmaceuticals Inc:

* RIGEL ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES COMPANY UPDATE

* Q1 LOSS PER SHARE $0.17

* Q1 EARNINGS PER SHARE VIEW $-0.18 -- THOMSON REUTERS I/B/E/S

* AS OF MARCH 31, HAD CASH, CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS OF $94.3 MILLION, VERSUS $115.8 MILLION AS OF DEC 31, 2017

* RIGEL - EXPECTS CASH, CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS TO BE SUFFICIENT THROUGH AT LEAST NEXT 12 MONTHS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below